On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1330 AM Sheboygan, WI

Weather

Current Conditions(Sheboygan,WI 53081)

More Weather »
57° Feels Like: 57°
Wind: S 5 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Mostly Clear 51°

Tomorrow

Partly Cloudy/Wind 67°

Fri Night

Thunderstorms 61°

Alerts

Breaking News

Travis Tramte has been found guilty of reckless homicide in the heroin overdose death of Kathryn Jakimczyk of July of 2013.

SHEBOYGAN, WI (WHBL) - Travis Tramte was found guilty Thursday of reckless homicide in the heroin overdose death of Kathryn Jakimczyk.  It took a jury over two hours to make their decision Thursday afternoon after hearing two days of testimony in Sheboygan County Court. Prosecutors said Tramte supplied Jakimczyk with the heroin that she injected at her North 9th Street apartment back in July of 2013 that led to her death.  Tramte’s lawyer tried to prove that there was other e...

Read More »

Mallinckrodt's extended-release pain drug meets main goal of study

By Vrinda Manocha

(Reuters) - Specialty pharmaceutical company Mallinckrodt Plc said its experimental painkiller significantly reduced the intensity of pain in patients who had undergone a surgical removal of bunions.

The drug, MNK-795, showed statistically significant improvement in pain scores over 48 hours, compared to a placebo in a late-stage trial.

During the study, subjects took two tablets of MNK-795 every 12 hours. The drug is also designed to resist abuse.

The drug is a combination of two older pain drugs acetaminophen and oxycodone. The combination, already available as generics in the market, is highly addictive and often abused by snorting or by injecting into the muscles or veins.

Endo Pharmaceuticals' Percocet and Johnson & Johnson unit Janssen Pharmaceuticals' Tylox are branded versions of the drug.

BMO Capital Markets analyst David Maris said MNK-795 sales could peak at $200 million by 2017.

Dublin-based Mallinckrodt, spun off from Covidien Plc in July, said common side effects associated with the drug included nausea, dizziness and headaches.

Shares of the company were up about 2 percent at $45.97 in afternoon trading on the Nasdaq.

(This story corrects in the third paragraph the frequency of dosage to say two MNK-795 tablets taken every 12 hours, not once a day. Also removes BMO Capital Markets analyst quote in the fourth paragraph)

(Reporting By Vrinda Manocha in Bangalore; Editing by Don Sebastian)

Comments